Abstract:Context: Obstructive sleep apnea (OSA) has been increasingly implicated in the initiation and progression of cardiovascular diseases. Objective: To systematically review the interactions of OSA with cardiovascular pathophysiology and diseases. Data sources and study selection: The MEDLINE database from January 1966 to March 2003 was searched using the Medical Subject Headings sleep, sleep apnea, obesity, hypertension, heart failure, cardiac arrhythmia, coronary artery disease, stroke, sympathetic activity, endothelium, inflammation, and continuous positive airway pressure (CPAP) to identify peer-reviewed studies of OSA. Priority was given to large prospective cohort studies and to randomized controlled trials. Data extraction: We identified 154 original investigations and reviews of sleep-related breathing disorders. Data from these studies were examined for relevance and extracted by one of the authors. Data synthesis: Approximately 1 in 5 adults has at least mild OSA (apnea-hypopnea index [ie, the number of apneic and hypopneic events per hour], 5-15), and 1 in 15 adults has at least moderate OSA (apnea-hypopnea index, 15-30). Repetitive apneic events disrupt the normal physiologic interactions between sleep and the cardiovascular system. Such sleep fragmentation, as well as abnormalities evident in patients with OSA (eg, increased sympathetic activation, vascular endothelial dysfunction, increased oxidative stress, inflammation, increased platelet aggregability, metabolic dysregulation), may be implicated in the initiation and progression of cardiac and vascular disease. Persuasive data implicate OSA in the development of hypertension, and OSA also may contribute to cardiac ischemia, congestive heart failure, cardiac arrhythmias, and perhaps also to cerebrovascular disease and stroke. Conclusions: Obstructive sleep apnea is common, readily diagnosed, and usually treatable. It frequently coexists undiagnosed in patients with cardiovascular disease, activates disease mechanisms known to elicit cardiac and vascular damage, and may be implicated in progression of cardiovascular disease and resistance to conventional therapeutic strategies. In the absence of definitive evidence from large-scale trials and a better understanding of potential cost-effectiveness, the likely benefits of diagnosis and treatment of OSA are presently best appraised on an individualized patient basis.

Sleep Apnea and Skin

Obstructive Sleep Apnea, Hypertension, and Cardiovascular Risk: Epidemiology, Pathophysiology, and Management

The Link Between Obstructive Sleep Apnea and Cardiovascular Disease

Interactions of Obstructive Sleep Apnea With the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review

Obstructive sleep apnea: implications for cardiac and vascular disease

Ocular Manifestations of Obstructive Sleep Apnea

Obstructive sleep apnoea and comorbidity - an overview of the association and impact of continuous positive airway pressure therapy

Exploring the link between vitamin D deficiency and obstructive sleep apnea: A comprehensive review

Obstructive sleep apnoea and cardiovascular complications: perception versus knowledge.

Association Between Obstructive Sleep Apnea and Cardiovascular Diseases.

Overview of Common Sleep Disorders and Intersection with Dermatologic Conditions

Oral Health Implications of Obstructive Sleep Apnea: A Literature Review

Obstructive sleep apnea and obesity: A review of epidemiology, pathophysiology and the effect of weight-loss treatments

Cardiovascular remodeling in obstructive sleep apnea: focus on arterial stiffness, left ventricular geometry and atrial fibrillation

Obstructive sleep apnea and comorbidities: a dangerous liaison

Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome

Treatment of OSA and its Impact on Cardiovascular Disease, Part 2: JACC State-of-the-Art Review

Exploring the links between periodontal diseases and obstructive sleep apnoea: An overview for clinicians

Diagnosis and treatment of obstructive sleep apnea and its impact on cardiovascular disease

Mild Sleep-Disordered Breathing and Cardiovascular Disease Risk

Obstructive sleep apnea-hypopnea syndrome immunological relationship